In 2008, Cymbalta became the second drug to receive FDA approval for the treatment of fibromyalgia. It was classified as a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant. At the time, the FM community was excited to have another medication available that … Continue reading →

You're reading Discontinuing Cymbalta may result in Severe Withdrawal Symptoms by Michelle Arbore, originally posted on Fibromyalgia, The pain I live with everyday. If you enjoyed this post, be sure to follow my Facebook page. You can also find me on Twitter.